Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
166.8 BRL | +1.86% | +0.48% | -13.36% |
05-07 | Ligand Pharmaceuticals Investing in Agenus to Fund Development of Oncology Drug Candidates | MT |
05-02 | UBS Adjusts Price Target on Gilead Sciences to $70 From $75, Maintains Neutral Rating | MT |